Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03878719
Title Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Array BioPharma
Indications
Therapies
Age Groups: child
Covered Countries ITA

Facility Status City State Zip Country Details
Fondazione IRCCS Istituto Nazionale Dei Tumori Milan Lombardy 20133 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field